The Sindh Drug Testing Laboratory (SDTL) has declared two auto-disable syringe samples manufactured by a Khyber Pakhtunkhwa-based pharmaceutical company as substandard after they failed mandatory quality tests.
According to the latest SDTL report, samples of both 5ml and 3ml auto-disable syringes did not meet the required standards under the Medical Devices Rules, 2017.
The laboratory said the syringes failed the auto-disable and reuse prevention tests, raising concerns over their safety for medical use.
SDTL Director General Adnan Rizvi said the syringes’ automatic safety mechanism did not function effectively during testing, making them unsuitable for safe injection practices. He warned that substandard auto-disable syringes could pose a risk to patients by increasing the possibility of unsafe reuse.
The report identified the rejected syringes as products of a pharmaceutical company based in Khyber Pakhtunkhwa but did not disclose the company’s name.
Following the findings, the test reports have been forwarded to the Drug Inspector Karachi East and the Secretary of the Quality Control Board for further action under the relevant regulations.
Auto-disable syringes are designed to prevent reuse after a single injection and are widely used to reduce the spread of blood-borne diseases through unsafe injection practices.
Get the latest news and stories wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.